Recalls and Alerts
-
Public Alert No. 01/2023 – Alert on Substandard (contaminated) METHOTREXTM 50mg identified in the WHO Eastern Mediterranean region
- January 9, 2023
- Posted by: nafdacadmin
- Category: Recalls and Alerts
No Comments -
Public Alert No. 050/2022 – Alert on Revoke of Drug Companies Licenses after 159 Infant deaths in Indonesia
- December 20, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 049/2022 – Alert on the UAE health authority warning against consumption of weight loss pills
- December 20, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 048/2022 – Warning Against Counterfeit Covid-19 Antigen Rapid Test Kits
- December 14, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 047/2022 – Alert On The Distribution And Sale Of Falsified Lantus Solostar Solution For Injection In Prefilled Pens 100 I.U
- December 14, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 046/2022 – Alert on the Distribution and Sale of Falsified Daonil 5mg Tablets
- December 14, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 045/2022 – Alert on Counterfeit Meronem circulating in Nigeria
- December 10, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No:044/2022 – Counterfeit Neo Medrol found in Circulation in Nigeria
- December 6, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No:0043 – Products Contaminated With Ethylene Glycol And/Or Diethylene Glycol
- November 6, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No: 42 – NAFDAC Alert And Sensitization Of The Public On Suspected Falsified Augmentin 625mg
- October 22, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts